Related Experiment Videos
[Does adenosine administration during the early reperfusion period affect ischemic preconditioning?]
1Division of Cardiothoracic Surgery, Beth Israel Deaconess Medical Center, Boston, Massaachusetts, USA.
The Japanese Journal of Thoracic and Cardiovascular Surgery : Official Publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai Zasshi
|October 31, 1998
Summary
Adenosine administration during early reperfusion enhances ischemic preconditioning (IPC) effects, significantly reducing myocardial infarct size and reperfusion injury in rabbit hearts. This intervention reinforces the protective benefits of IPC against ischemic damage.
Area of Science:
- Cardiovascular Physiology
- Myocardial Ischemia and Reperfusion Injury
- Pharmacology
Context:
- Ischemic preconditioning (IPC) is a phenomenon where brief episodes of ischemia protect the heart against subsequent longer ischemic insults.
- Adenosine is a nucleoside with known cardioprotective properties, often released during ischemia.
- The precise timing and mechanism by which adenosine influences IPC, particularly during the early reperfusion phase, require further elucidation.
Purpose:
- To investigate whether adenosine administration during the early reperfusion period can augment the protective effects of ischemic preconditioning (IPC).
- To determine the impact of adenosine combined with IPC on infarct size and post-ischemic functional recovery in an isolated rabbit heart model.
- To assess the reduction in myocardial necrosis and reperfusion injury when adenosine is administered during early reperfusion following ischemic insult.
Summary:
- Twenty-four rabbit hearts underwent 30 minutes of global ischemia and 120 minutes of reperfusion, divided into four groups: Global Ischemia (GI), Control, Ischemic Preconditioned (IPC), and IPC + Adenosine (Ado).
- The IPC + Ado group received adenosine (100 µmol/L) during the initial 3 minutes of reperfusion.
- Results showed significantly reduced infarct size in the IPC group (13.8%) and even more so in the IPC + Ado group (8.1%) compared to the GI group (32.9%). Post-ischemic functional recovery was initially better in the IPC + Ado group.
Impact:
- Adenosine administration during early reperfusion significantly reinforces the cardioprotective effects of IPC, leading to a greater reduction in myocardial infarct size.
- This combined approach effectively reduces myocardial reperfusion injury, suggesting a synergistic protective mechanism.
- The findings highlight the critical role of the early reperfusion period and adenosine in mitigating ischemic damage, offering potential therapeutic strategies for myocardial infarction.